Publications:44
Accepting New Patients
Book an Appointment
About Me
Raymund Yong, MD, Associate Professor of Neurosurgery, specializes in the diagnosis and treatment of malignant and benign brain tumors, and he also has an interest in general disorders of the brain and spine. He has subspecialty fellowship training in the removal of infiltrative tumors from eloquent regions of the brain—including the areas for language and motor function—using computer-guided navigation, brain mapping techniques, and awake surgery. Dr. Yong also has a strong research interest in using new insights on how gliomas originate and evolve through time to develop innovative treatment strategies for his patients. He has received several national and international awards for his work in stem cells and cancer genetics. He also collaborates with other investigators and institutions to enroll patients in clinical trials studying the latest experimental treatments.
Dr. Yong’s laboratory is interested in characterizing the initial genetic and epigenetic events that give rise to malignant brain tumors. Additionally, the lab seeks to understand how current standard treatment regimes, such as radiation therapy and chemotherapy, interact with the cancer genome to influence the way in which tumor cells change through time and diversify in different compartments in the brain. The inherent genetic instability of cancer cells and their resulting adaptive abilities is a major reason why gliomas inevitably recur following treatment and are ultimately fatal. A greater understanding of the cancer genome as a dynamic, three-dimensional structure will lead to the development of new strategies that attempt to address cancer evolution directly.
Read about Dr. Yong's patient who went "Back to Bowling from Brain Surgery."
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Raymund Yong, MD, Associate Professor of Neurosurgery, specializes in the diagnosis and treatment of malignant and benign brain tumors, and he also has an interest in general disorders of the brain and spine. He has subspecialty fellowship training in the removal of infiltrative tumors from eloquent regions of the brain—including the areas for language and motor function—using computer-guided navigation, brain mapping techniques, and awake surgery. Dr. Yong also has a strong research interest in using new insights on how gliomas originate and evolve through time to develop innovative treatment strategies for his patients. He has received several national and international awards for his work in stem cells and cancer genetics. He also collaborates with other investigators and institutions to enroll patients in clinical trials studying the latest experimental treatments.
Dr. Yong’s laboratory is interested in characterizing the initial genetic and epigenetic events that give rise to malignant brain tumors. Additionally, the lab seeks to understand how current standard treatment regimes, such as radiation therapy and chemotherapy, interact with the cancer genome to influence the way in which tumor cells change through time and diversify in different compartments in the brain. The inherent genetic instability of cancer cells and their resulting adaptive abilities is a major reason why gliomas inevitably recur following treatment and are ultimately fatal. A greater understanding of the cancer genome as a dynamic, three-dimensional structure will lead to the development of new strategies that attempt to address cancer evolution directly.
Read about Dr. Yong's patient who went "Back to Bowling from Brain Surgery."
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Acromegaly
- Astrocytoma
- Benign Neoplasm
- Biopsy
- Bone Hemangioma
- Brain / Spinal Cord Cancer
- Brain Cyst
Show More
Education
MD, University of Maryland School of Medicine
Residency, Neurosurgery
University Of British Columbia Faculty Of Medicine
Certifications
American Board of Neurological Surgery
Awards
2012
Young Investigator Award
American Brain Tumor Association
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Mount Sinai Doctors Faculty Practice5 East 98th Street, 7th Floor, New York, NY, 10029
- Mount Sinai Doctors - Astoria25-20 30th Avenue, 5th Floor, Astoria, NY, 11102
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Performance of Radiomics-based machine learning and deep learning-based methods in the prediction of tumor grade in meningioma: a systematic review and meta-analysis. Roozbeh Tavanaei, Mohammadhosein Akhlaghpasand, Alireza Alikhani, Bardia Hajikarimloo, Ali Ansari, Raymund L. Yong, Konstantinos Margetis. Neurosurgical Review
- Performance of Machine Learning Models in Predicting BRAF Alterations Using Imaging Data in Low-Grade Glioma: A Systematic Review and Meta-Analysis. Shahryar Rajai Firouzabadi, Roozbeh Tavanaei, Ida Mohammadi, Alireza Alikhani, Ali Ansari, Mohammadhosein Akhlaghpasand, Bardia Hajikarimloo, Raymund L. Yong, Konstantinos Margetis. World Neurosurgery
- Radiomic Consensus Clustering in Glioblastoma and Association with Gene Expression Profiles. Tadeusz H. Wroblewski, Mert Karabacak, Carina Seah, Raymund L. Yong, Konstantinos Margetis. Cancers
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Yong has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Yong has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.